| |
| Issue |
Title |
| |
| Vol 20, No 3E (2024) |
Potential of Humic Substances in the Concomitant Therapy of Cancer Patients |
Abstract
PDF (Rus)
|
|
N. S. Benderskii, A. V. Safronenko, E. V. Gantsgorn, O. M. Kudelina, A. V. Moroz |
| |
| Vol 20, No 3E (2024) |
Drug-Induced Liver Damage when Using Cephalosporins |
Abstract
PDF (Rus)
|
|
I. V. Zamlelaya, A. V. Safronenko, N. V. Sukhorukova, A. V. Kapliev, A. V. Krishtopa, S. S. Khrkhrian |
| |
| Vol 20, No 3E (2024) |
Assessment of the Effect of A1166C Polymorphic Marker of Angiotensin II Type 1 Receptor Gene (AGTR1) on the Dynamics of Daily Blood Pressure in Patients with Stage 1–2 Arterial Hypertension |
Abstract
PDF (Rus)
|
|
E. V. Rebrova, E. V. Shikh |
| |
| Vol 19, No 4 (2023) |
Results of Phase III Clinical Trial: a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Direkord in Ischemic Stroke Patients in Early Recovery Period |
Abstract
PDF (Rus)
|
|
I. A. Pomytkin, V. V. Pisarev, M. E. Merkulov, L. V. Lukinykh, M. V. Morzhukhina, N. N. Karkischenko |
| |
| Vol 19, No 3E (2023) |
Clinical Course and Therapy Methods of Aquagenic Urticaria |
Abstract
PDF (Rus)
|
|
O. M. Kudelina, E. V. Gantsgorn, Yu. S. Maklyakov, D. L. Tkachenko, L. A. Avakyan, P. A. Chubyreva, Y. G. Amirova, Yu. A. Karpova, A. N. Dulskaya, I. B. Meshi |
| |
| Vol 19, No 3 (2023) |
Phase II Clinical Trial of Direkord: Randomized, Double-Blind, Placebo-Controlled, Parallel Group, and Prospective Studies to Select Optimal Dosage and to Study the Efficacy, Safety, and Tolerability in Ischemic Stroke Patients in the Early Recovery Period |
Abstract
PDF (Rus)
|
|
I. A. Pomytkin, V. V. Pisarev, M. E. Merkulov, E. B. Kuznetsova, E. A. Salina, A. Yu. Malygin, N. N. Karkischenko |
| |
| Vol 19, No 2 (2023) |
Results of a Phase I Open-Label Clinical Trial of Direkord in Healthy Volunteers |
Abstract
PDF (Rus)
|
|
I. A. Pomytkin, V. V. Pisarev, M. E. Merkulov, S. M. Noskov, N. N. Karkischenko |
| |
| Vol 18, No 2 (2022) |
Chronic Compensated Tonsillopharingitis: Clinical and Microbiological Features |
Abstract
PDF (Rus)
|
|
E. K. Meloyan, A. V. Safronenko, E. V. Gantsgorn, V. I. Polyakova, S. D. Stagniev, A. A. Ilyina, E. Yu. Romanova |
| |
| Vol 18, No 2 (2022) |
Analysis of Spontaneous Reports as a Methodological Pharmacovigilance Tool |
Abstract
PDF (Rus)
|
|
T. S. Litvinenko, A. V. Safronenko, Yu. S. Maklyakov, E. V. Gantsgorn, E. S. Postnikova, M. O. Gaisaev, V. G. Brizhak |
| |
| Vol 17, No 3E (2021) |
Bioinformatical analysis of the level of osteomarkers in the gingival fluid in systemic osteoporosis and local osteo-destructive processes in the dentoalveolar region |
Abstract
PDF (Rus)
|
|
A. V. Safronenko, V. A. Kosenko, G. A. Airapetov, I. A. Demidov, M. I. Nazheva, V. M. Polyakov |
| |
| Vol 17, No 3E (2021) |
Pharmacological optimization of premedication to reduce the risk of cardiovascular complications |
Abstract
PDF (Rus)
|
|
A. V. Safronenko, Yu. S. Maklyakov, S. V. Lepyavka, I. A. Demidov, A. A. Demidova, I. V. Dubatova |
| |
| Vol 17, No 3 (2021) |
1,3-Diethylbenzimidazolium Triodide in Pharmacotherapy of Chronic Compensated Tonsillopharyngitis |
Abstract
PDF (Rus)
|
|
E. K. Meloyan, A. V. Safronenko, E. V. Gantsgorn, L. E. Hmara, A. O. Golubeva, M. A. Jabr |
| |
| 1 - 12 of 12 Items |
|
